Christophe Queva

Company: Oncorus

Job title: Chief Scientific Officer

Seminars:

Optimization of an Oncolytic HSV-1 for the Treatment of Glioblastoma 3:10 pm

Optimization of oHSV backbone 7 Transgenes Development of clinical candidate oncolytic virusRead more

day: Day Two